Patricia G. Gauthier - 31 Aug 2026 Form 4 Insider Report for Decoy Therapeutics Inc. (DCOY)

Reporting relationship
Director
Issuer ticker
DCOY
Reported as of
31 Aug 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Sep 2026, 17:39:18 UTC
Prior SEC filing
31 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Mark Rosenblum, as Attorney -in-Fact

Key filing fact

Patricia G. Gauthier filed Form 4 for Decoy Therapeutics Inc. (DCOY) on 02 Sep 2026.

Key facts

  • This page summarizes Patricia G. Gauthier's Form 4 filing for Decoy Therapeutics Inc. (DCOY).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Sep 2026, 17:39.

Change

  • Previous filing in this sequence was filed on 31 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002148287 Primary reporting owner

Gauthier Patricia G.

Relationship
Director
Address
2450 HOLCOMBE BLVD., SUITE X, HOUSTON
Signature
/s/Mark Rosenblum, as Attorney -in-Fact
Signature date
02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DCOY transaction

Common Stock

Award

Transaction value
Shares
+2,000
Change %
Price
$0.000000*
Shares after
2,000
Date
31 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan, 100 percent will vest on August 30, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .